Proposed Settlement in Vanda Pharmaceuticals Derivative Action

News Page

Published July 23, 2021

NEW YORK, July 23, 2021 – Levi & Korsinsky, LLP announces the proposed settlement of the derivative action captioned In re Vanda Pharmaceuticals Inc. Derivative Litigation, Case No. 1:19-cv-04293-FB-LB in the United States District Court for the Eastern District of New York.   If you were a stockholder of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) as of July 19, 2021 and continue to own such shares, please click HERE to read the Notice to Current Vanda Stockholders, which contains important information regarding your rights.   Please reach out to counsel for Plaintiffs with any questions or concerns at:  

Counsel for Plaintiffs:

Gregory M. Nespole

Daniel Tepper

LEVI & KORSINSKY, LLP

55 Broadway, 10th Floor

New York NY 10006

Phone: (212) 363-7500

Fax: (212) 363-7171

   

W. Scott Holleman

Garam Choe

BRAGAR EAGEL & SQUIRE, P.C.

810 Seventh Avenue, Suite 620

New York, NY 10019

Fax: (212) 486-0462